PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC
Sally C. M. Lau, Madhumitha Rabindranath, Jessica Weiss, Janice J.N. Li, Andrea S. Fung, Dorinda Mullen, Najd Alshamlan, Heather Ruff, Leung Chu Tong, Prodipto Pal, Michael Cabanero, Ying-Han R. Hsu, Adrian G. Sacher, Frances A. Shepherd, Geoffrey Liu, Penelope A. Bradbury, Kazuhiro Yasufuku, Katarzyna Czarnecka‐Kujawa, Hyang Mi Ko, Ming‐Sound Tsao, Natasha B. Leighl, Joerg Schwock
Topics & Concepts
CytologyMedicineHistologyInternal medicineLung cancerPD-L1BiomarkerOncologyCancerPathologyGastroenterologyImmunotherapyBiologyBiochemistryCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Diagnosis and Treatment